{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:23:19Z","timestamp":1785522199963,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drugs. Recently, it has determined that gastric proton-pump inhibitors (PPI) have anti-giardiasic activity. The glycolytic enzyme, triosephosphate isomerase (GlTIM), is one of its potential targets. Therefore, we employed the scaffold of PPI to design new compounds aimed to increase their antigiardial capacity by inactivating GlTIM. Here we demonstrated that two novel PPI-derivatives (<jats:bold>BHO2<\/jats:bold> and <jats:bold>BHO3)<\/jats:bold>, have better anti-giardiasic activity than omeprazole in concentrations around 120\u2013130\u2009\u00b5M, without cytotoxic effect on mammal cell cultures. The derivatives inactivated GlTIM through the chemical modification of Cys222 promoting local structural changes in the enzyme. Furthermore, derivatives forms adducts linked to Cys residues through a C-S bond. We demonstrated that PPI can be used as scaffolds to design better antiparasitic molecules; we also are proposing a molecular mechanism of reaction for these novel derivatives.<\/jats:p>","DOI":"10.1038\/s41598-017-07612-y","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T13:53:20Z","timestamp":1501854800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation"],"prefix":"10.1038","volume":"7","author":[{"given":"B.","family":"Hern\u00e1ndez-Ochoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-4762","authenticated-orcid":false,"given":"G.","family":"Navarrete-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nava-Zuazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Castillo-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. T.","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Torres-Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"G\u00f3mez-Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Marcial-Quino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ponce-Macotela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Rufino-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mart\u00ednez-Gordillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Palencia-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0915-5346","authenticated-orcid":false,"given":"N.","family":"Esturau-Escofet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Calderon-Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Oria-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Reyes-Vivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"7612_CR1","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.3748\/wjg.v19.i47.8974","volume":"19","author":"MC Halliez","year":"2013","unstructured":"Halliez, M. C. & Buret, A. G. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol. \n                           19, 8974\u201385 (2013).","journal-title":"World J Gastroenterol."},{"key":"7612_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.ijpara.2013.06.001","volume":"43","author":"U Ryan","year":"2013","unstructured":"Ryan, U. & Cacci\u00f2, S. M. Zoonotic potential of Giardia. Int J Parasitol. \n                           43, 943\u201356 (2013).","journal-title":"Int J Parasitol."},{"key":"7612_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0140-6736(02)07744-9","volume":"359","author":"DS Berkman","year":"2002","unstructured":"Berkman, D. S., Lescano, A. G., Gilman, R. H., Lopez, S. L. & Black, M. M. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet. \n                           359, 564\u201371 (2002).","journal-title":"Lancet."},{"key":"7612_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.1992.47.28","volume":"47","author":"RL Guerrant","year":"1992","unstructured":"Guerrant, R. L., Schorling, J. B., McAuliffe, J. F. & de Souza, M. A. Diarrhea as a cause and an effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration. Am J Trop Med Hyg. \n                           47, 28\u201335 (1992).","journal-title":"Am J Trop Med Hyg."},{"key":"7612_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.pt.2006.02.015","volume":"22","author":"L Savioli","year":"2006","unstructured":"Savioli, L., Smith, H. & Thompson, A. Giardia and Cryptosporidium join the \u2018Neglected Diseases Initiative\u2032. Trends Parasitol. \n                           22, 203\u20138 (2006).","journal-title":"Trends Parasitol."},{"key":"7612_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0020-7519(00)00127-2","volume":"30","author":"RC Thompson","year":"2000","unstructured":"Thompson, R. C. Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int J Parasitol. \n                           30, 1259\u201367 (2000).","journal-title":"Int J Parasitol."},{"key":"7612_CR7","doi-asserted-by":"crossref","unstructured":"Ali, S. A. & Hill, D. R. Giardia intestinalis. Curr Opin Infect Dis. 16, 453\u201360 (2003).","DOI":"10.1097\/00001432-200310000-00012"},{"key":"7612_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrmicro2317","volume":"8","author":"J Ankarklev","year":"2010","unstructured":"Ankarklev, J., Jerlstr\u00f6m-Hultqvist, J., Ringqvist, E., Troell, K. & Sv\u00e4rd, S. G. Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev Microbiol. \n                           8, 413\u201322 (2010).","journal-title":"Nat Rev Microbiol."},{"key":"7612_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/1040-840291046713","volume":"28","author":"S Lane","year":"2002","unstructured":"Lane, S. & Lloyd, D. Current trends in research into the waterborne parasite Giardia. Crit Rev Microbiol. \n                           28, 123\u201347 (2002).","journal-title":"Crit Rev Microbiol."},{"key":"7612_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0169-4758(93)90144-5","volume":"9","author":"JA Upcroft","year":"1993","unstructured":"Upcroft, J. A. & Upcroft, P. Drug resistance and Giardia. Parasitol Today. \n                           9, 187\u201390 (1993).","journal-title":"Parasitol Today."},{"key":"7612_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","volume":"14","author":"TB Gardner","year":"2001","unstructured":"Gardner, T. B. & Hill, D. R. Treatment of giardiasis. Clin. Microbiol Rev. \n                           14, 114\u201328 (2001).","journal-title":"Clin. Microbiol Rev."},{"key":"7612_CR12","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1099\/mic.0.2007\/010041-0","volume":"153","author":"M Sterk","year":"2007","unstructured":"Sterk, M., M\u00fcller, J., Hemphill, A. & M\u00fcller, N. Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin. Microbiology. \n                           153, 4150\u20138 (2007).","journal-title":"Microbiology."},{"key":"7612_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/jac\/dkm205","volume":"60","author":"J M\u00fcller","year":"2007","unstructured":"M\u00fcller, J., Sterk, M., Hemphill, A. & M\u00fcller, N. Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother. \n                           60, 280\u20137 (2007).","journal-title":"J Antimicrob Chemother."},{"key":"7612_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/187152610791591610","volume":"10","author":"M Lalle","year":"2010","unstructured":"Lalle, M. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. Infect Disord Drug Targets. \n                           10, 283\u201394 (2010).","journal-title":"Infect Disord Drug Targets."},{"key":"7612_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s11908-014-0396-y","volume":"16","author":"RR Watkins","year":"2014","unstructured":"Watkins, R. R. & Eckmann, L. Treatment of giardiasis: current status and future directions. Curr Infect Dis Rep. \n                           16, 396 (2014).","journal-title":"Curr Infect Dis Rep."},{"key":"7612_CR16","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1128\/AAC.02900-14","volume":"58","author":"H Reyes-Vivas","year":"2014","unstructured":"Reyes-Vivas, H. et al. Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia. Antimicrob Agents Chemother. \n                           58, 7072\u201382 (2014).","journal-title":"Antimicrob Agents Chemother."},{"key":"7612_CR17","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1016\/j.bmcl.2011.10.028","volume":"21","author":"J P\u00e9rez-Villanueva","year":"2011","unstructured":"P\u00e9rez-Villanueva, J. et al. Antiprotozoal activity of proton-pump inhibitors. Bioorg Med Chem Lett. \n                           21, 7351\u20134 (2011).","journal-title":"Bioorg Med Chem Lett."},{"key":"7612_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.14.3.447-475.2001","volume":"14","author":"RD Adam","year":"2001","unstructured":"Adam, R. D. Biology of Giardia lamblia. Clin Microbiol Rev. \n                           14, 447\u201375 (2001).","journal-title":"Clin Microbiol Rev."},{"key":"7612_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nature01945","volume":"426","author":"J Tovar","year":"2003","unstructured":"Tovar, J. et al. Mitochondrial remnant organelles of Giardia function in iron-sulphur protein maturation. Nature. \n                           426, 172\u20136 (2003).","journal-title":"Nature."},{"key":"7612_CR20","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.bmc.2015.02.059","volume":"23","author":"G Navarrete-V\u00e1zquez","year":"2015","unstructured":"Navarrete-V\u00e1zquez, G. et al. Synthesis of nitro(benzo)thiazole acetamides and in vitro antiprotozoal effect against amitochondriate parasites Giardia intestinalis and Trichomonas vaginalis. Bioorg Med Chem. \n                           23, 2204\u201310 (2015).","journal-title":"Bioorg Med Chem."},{"key":"7612_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molbiopara.2007.10.013","volume":"157","author":"S Enriquez-Flores","year":"2008","unstructured":"Enriquez-Flores, S. et al. Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer. Mol Biochem Parasitol. \n                           157, 179\u201386 (2008).","journal-title":"Mol Biochem Parasitol."},{"key":"7612_CR22","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/prot.23100","volume":"79","author":"S Enr\u00edquez-Flores","year":"2011","unstructured":"Enr\u00edquez-Flores, S. et al. Determining the molecular mechanism of inactivation by chemical modification of triosephosphate isomerase from the human parasite Giardia lamblia: a study for antiparasitic drug design. Proteins. \n                           79, 2711\u201324 (2011).","journal-title":"Proteins."},{"key":"7612_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbagen.2015.10.021","volume":"1860","author":"I Garc\u00eda-Torres","year":"2016","unstructured":"Garc\u00eda-Torres, I. et al. Proton pump inhibitors drastically modify triosephosphate isomerase from Giardia lamblia at functional and structural levels, providing molecular leads in the design of new antigiardiasic drugs. Biochim Biophys Acta. \n                           1860, 97\u2013107 (2016).","journal-title":"Biochim Biophys Acta."},{"key":"7612_CR24","doi-asserted-by":"publisher","first-page":"e69031","DOI":"10.1371\/journal.pone.0069031","volume":"8","author":"G Hern\u00e1ndez-Alc\u00e1ntara","year":"2013","unstructured":"Hern\u00e1ndez-Alc\u00e1ntara, G. et al. Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region. PLoS One. \n                           8, e69031 (2013).","journal-title":"PLoS One."},{"key":"7612_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jmb.2006.10.053","volume":"365","author":"H Reyes-Vivas","year":"2007","unstructured":"Reyes-Vivas, H. et al. Disulfide bridge in the mesophilic triosephosphate isomerase from Giardia lamblia are related to oligomerization and activity. J. Mol. Biol. \n                           365, 752\u2013763 (2007).","journal-title":"J. Mol. Biol."},{"key":"7612_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/poc.1896","volume":"25","author":"J Reyes-Gonz\u00e1lez","year":"2012","unstructured":"Reyes-Gonz\u00e1lez, J., G\u00f3mez, R. M. & Cort\u00e9s-Guzm\u00e1n, F. Theoretical study of the miles rearrangement in the activation mechanism of proton pump inhibitors. J. Phys. Org. Chem. \n                           25, 230\u2013238 (2012).","journal-title":"J. Phys. Org. Chem."},{"key":"7612_CR27","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1128\/AAC.03834-14","volume":"58","author":"L Kulakova","year":"2014","unstructured":"Kulakova, L. et al. Discovery of novel antigiardiasis drug candidates. Antimicrob Agents Chemother. \n                           58, 7303\u201311 (2014).","journal-title":"Antimicrob Agents Chemother."},{"key":"7612_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/jac\/dkr029","volume":"66","author":"D Nillius","year":"2011","unstructured":"Nillius, D., M\u00fcller, J. & M\u00fcller, N. J. Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. Antimicrob Chemother. \n                           66, 1029\u201335 (2011).","journal-title":"Antimicrob Chemother."},{"key":"7612_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.bmc.2006.07.068","volume":"15","author":"KS Jain","year":"2007","unstructured":"Jain, K. S. et al. Recent advances in proton pump inhibitors and management of acid-peptic disorders. Ioorg Med Chem. \n                           15, 1181\u2013205 (2007).","journal-title":"Ioorg Med Chem."},{"key":"7612_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0005-2736(84)90406-1","volume":"778","author":"B Wallmark","year":"1984","unstructured":"Wallmark, B., Br\u00e4ndstr\u00f6m, A. & Larsson, H. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H\u2009+\u2009K+)-ATPase within the parietal cell. Biochim Biophys Acta. \n                           778, 549\u201358 (1984).","journal-title":"Biochim Biophys Acta."},{"key":"7612_CR31","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/S0021-9258(18)89112-8","volume":"260","author":"WB Im","year":"1985","unstructured":"Im, W. B., Sih, J. C., Blakeman, D. P. & McGrath, J. P. Omeprazole, a specific inhibitor of gastric (H\u2009+\u2009\u2212\u2009K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups. J Biol Chem. \n                           260, 4591\u20137 (1985).","journal-title":"J Biol Chem."},{"key":"7612_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","volume":"26","author":"P Csermely","year":"2005","unstructured":"Csermely, P., \u00c1goston, V. & Pongor, S. The efficiency of multi-target drugs: the network approach might help drug drug design. Trends in Pharmacological Science. \n                           26, 178\u2013182 (2005).","journal-title":"Trends in Pharmacological Science."},{"key":"7612_CR33","first-page":"2702","volume":"1834","author":"I De La Mora-De La Mora","year":"2013","unstructured":"De La Mora-De La Mora, I. et al. The E104D mutation increases the susceptibility of human triosephosphate isomerase to proteolysis. Asymmetric cleavage of the two monomers of the homodimeric enzyme. Biochim Biophys Acta. \n                           1834, 2702\u201311 (2013).","journal-title":"Asymmetric cleavage of the two monomers of the homodimeric enzyme. Biochim Biophys Acta."},{"key":"7612_CR34","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/prot.20097","volume":"55","author":"G L\u00f3pez-Vel\u00e1zquez","year":"2004","unstructured":"L\u00f3pez-Vel\u00e1zquez, G. et al. An unusual triosephosphate isomerase from the early divergent eukaryote Giardia lamblia. Proteins. \n                           55, 824\u201334 (2004).","journal-title":"Proteins."},{"key":"7612_CR35","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1021\/bi002619j","volume":"40","author":"H Reyes-Vivas","year":"2001","unstructured":"Reyes-Vivas, H. et al. Factors that control the reactivity of the interface cysteine of triosephosphate isomerase from Trypanosoma brucei and Trypanosoma cruzi. Biochemistry. \n                           40, 3134\u201340 (2001).","journal-title":"Biochemistry."},{"key":"7612_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0003-9861(58)90014-6","volume":"74","author":"GL Ellman","year":"1958","unstructured":"Ellman, G. L. A colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys. \n                           74, 443\u201350 (1958).","journal-title":"Arch Biochem Biophys."},{"key":"7612_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nbt.3109","volume":"33","author":"M Vaudel","year":"2015","unstructured":"Vaudel, M. et al. PeptideShaker enables reanalysis of MS-derived proteomics data sets. Nat Biotechnol. \n                           33, 22\u20134 (2015).","journal-title":"Nat Biotechnol."},{"key":"7612_CR38","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/bioinformatics\/bth092","volume":"20","author":"R Craig","year":"2004","unstructured":"Craig, R. & Beavis, R. C. TANDEM: matching proteins with tandem mass spectra. Bioinformatics. \n                           20, 1466\u20137 (2004).","journal-title":"Bioinformatics."},{"key":"7612_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1021\/pr0604054","volume":"6","author":"DL Tabb","year":"2007","unstructured":"Tabb, D. L., Fernando, C. G. & Chambers, M. C. MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis. J Proteome Res. \n                           6, 654\u201361 (2007).","journal-title":"J Proteome Res."},{"key":"7612_CR40","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1038\/ncomms6277","volume":"5","author":"S Kim","year":"2014","unstructured":"Kim, S. & Pevzner, P. A. MS-GF+ makes progress towards a universal database search tool for proteomics. Nat Commun. \n                           5, 5277 (2014).","journal-title":"Nat Commun."},{"key":"7612_CR41","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/pr0499491","volume":"3","author":"LY Geer","year":"2004","unstructured":"Geer, L. Y. et al. Open mass spectrometry search algorithm. J Proteome Res. \n                           3, 958\u201364 (2004).","journal-title":"J Proteome Res."},{"key":"7612_CR42","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s13361-015-1179-x","volume":"26","author":"JK Eng","year":"2015","unstructured":"Eng, J. K. et al. A deeper look into Comet-implementation and features. J Am Soc Mass Spectrom. \n                           26, 1865\u201374 (2015).","journal-title":"J Am Soc Mass Spectrom."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07612-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07612-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07612-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:25:04Z","timestamp":1671783904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07612-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7612"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07612-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]},"assertion":[{"value":"31 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7810"}}